Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents 
Supplementary Figure 2: Michaelis-Menten plots for the utilization of 3-Eth-5-NITP by pol delta (o) and pol eta (•)
during the replication of an abasic site. Kinetic studies were performed using an assay buffer consisting of 50 mM TrisOAc, 1 mg/ mL bovine serum albumin, 10 mM DTT, and 5 mM MgCl 2 at pH 7.5. All assays were performed at 37°C. Data for the dependency of rate as a function of nucleotide concentration were fit to the Michaelis-Menten equation
, where ν is the rate constant of product formation (1/s), V max is the maximal rate constant of polymerization, K m is the Michaelis constant for 3-Eth-5-NITP, and [3-Eth-5-NITP] is the concentration of nucleotide substrate.
Supplementary Figure 3:
Chain-termination capabilities of 3-Eth-NITP against high fidelity DNA polymerases. Assays were performed using pseudo-first order reaction conditions in which a limiting concentration of the bacteriophage T4 DNA polymerase or human pol delta (25 nM) was pre-incubated with 500 nM DNA containing an abasic site in assay buffer and then mixed with a fixed concentration of 3-Eth-5-NITP (5 µM) to initiate insertion opposite the lesion. After 4 half-lives, an aliquot of dTTP and dGTP (500 µM final concentration) was added to initiate the elongation reaction. Aliquots of the reactions were quenched with 200 mM EDTA at variable times (0-30 minutes) and analyzed by denaturing gel electrophoresis to assess elongation beyond 3-Eth-5-NITP.
